导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 20.56% | 269/4773 |
| 近一周 | -2.43% | 2138/5462 |
| 近一月 | -4.53% | 2544/5421 |
| 近一季 | -3.18% | 1365/5209 |
| 近半年 | 19.86% | 163/4920 |
| 近一年 | 21.76% | 368/4366 |
| 近两年 | 122.71% | 380/2954 |
| 近三年 | 75.50% | 250/2253 |
| 成立以来 | 54.31% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.54% 3646/4961 |
43.42% 704/5312 |
- - |
- - |
| 2025 | 40.96% 752/4813 |
1.98% 1503/3635 |
3.40% 1019/4076 |
40.26% 769/4524 |
-4.68% 3473/4813 |
| 2024 | 2.68% 1962/3463 |
-3.48% 1508/2808 |
-7.47% 2087/3014 |
13.07% 2251/3129 |
1.68% 1040/3463 |
| 2023 | 4.78% 216/2656 |
14.26% 247/2280 |
0.80% 274/2385 |
-8.31% 1691/2515 |
-0.79% 254/2655 |
| 2022 | -27.77% 1507/2207 |
-16.99% 1169/1919 |
-3.16% 1801/2016 |
-16.81% 1504/2113 |
8.01% 277/2208 |
| 2021 | 2.61% 629/1822 |
-6.95% 1050/1255 |
16.60% 200/1330 |
-10.25% 1218/1466 |
5.38% 296/1822 |
| 2020 | 31.65% 498/1250 |
4.03% 93/1028 |
22.65% 202/1067 |
1.87% 1019/1164 |
1.28% 1039/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 嘉实新兴科技100ETF联接C VS. 长安沪深300非周期A(740101) |